> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Draft Guide on Rare Disease Pre-IND Meetings
- URL: https://www.fdaweb.com/fda-draft-guide-on-rare-disease-pre-ind-meetings/
- Published: 2018-10-15T12:00:00.000Z
- Updated: 2026-09-15T00:38:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142581

*Federal Register* notice: FDA has made available a draft guidance entitled “Rare Diseases: Early Drug Development and the Role of Pre-Investigational New Drug Application Meetings.” The document offers recommendations on planning and conducting more efficient and productive pre-IND meetings. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-22435.pdf?ref=fdaweb.com).